Using metabolomics to predict severe traumatic brain injury outcome (GOSE) at 3 and 12 months

Using metabolomics to predict severe traumatic brain injury outcome (GOSE) at 3 and 12 months

Abstract Background Prognostication is very important to clinicians and families during the early management of severe traumatic brain injury (sTBI), however, there are no gold standard biomarkers to determine prognosis in sTBI. As has been demonstrated in several diseases, early measurement of seru...

Full description

Bibliographic Details
Main Authors: Mohammad M. Banoei, Chel Hee Lee, James Hutchison, William Panenka, Cheryl Wellington, David S. Wishart, Brent W. Winston, the Canadian biobank, database for Traumatic Brain Injury (CanTBI) investigators, the Canadian Critical Care Translational Biology Group (CCCTBG), the Canadian Traumatic Brain Injury Research, Clinical Network (CTRC)
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Critical Care
Subjects:
Severe TBI
Metabolomics
Outcome prediction
Prediction modelling
Online Access:https://doi.org/10.1186/s13054-023-04573-9

Internet

https://doi.org/10.1186/s13054-023-04573-9

Similar Items